Is ESSA Pharma Inc. (EPIX) a Buy, Sell, or Hold?
NASDAQ : EPIX
ESSA Pharma Inc.
$0.2012 USD
$0.0 (-1.85%)
- Volume
- 5.95M
- Average Volume
- 6.75M
- Market Capitalization
- $9.52M
- P/E Ratio
- -0.87
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $6.45
- Year Low
- $0.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $69.07
Company Overview
NASDAQ
David Ross Parkinson
Biotechnology
Healthcare
EPIX
35
CA
USD
Liquidity Metrics
0.00
69.07
69.07
53.72
0.00
Sales & Valuation
-$
0.00
0.08
-0.86
-0.25
Profitability
-$0.64
-$28.54M
0.00%
0.00%
-9.33%
-9.39%
P/E Metrics
-0.87
-0.11
-0.11
Analyst Price Target & Rating
$9.50
$17.00
$2.00
0/5
5 Analysts
-97.88%
Financial Health Scores
1.05
3/9
$108.9M
$110.5M
$1.6M
-$27.64M
Key Metrics (TTM)
-$76.43M
0.00
6.75
69.07
-9.33%
-11.37%
-116.20%
-116.08%
-8771 days
Company Executives
| Name | Title |
|---|---|
| David Ross Parkinson | President, Chief Executive Officer & Director |
| Neil Thapar | Executive |
| Peter A. Virsik | Executive Vice President & Chief Operating Officer |
| Alessandra Cesano | Chief Medical Officer & Executive Vice President |
| Erin Rudsinski | Executive |
| David S. Wood | Chief Financial Officer |
| Nkengyal Barber | Executive |
| Chandtip Chandhasin | Executive |
| Loleta Harris | Executive |
| Erica Osbourne | Executive |
Poll Results
No votes yet today — be the first to share your view!
About ESSA Pharma Inc. (NASDAQ:EPIX) Stock
ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's primary drug candidate is EPI-7386, an oral treatment presently undergoing Phase I clinical trials. This investigational compound is intended for individuals suffering from metastatic castration-resistant prostate cancer. Furthermore, ESSA Pharma has established collaborative partnerships with organizations including Caris Life Sciences, Inc., Bayer Consumer Care AG, Janssen Research & Development, LLC, and Astellas Pharma Inc. Founded in 2009, the company's corporate offices are located in Vancouver, Canada. ...
Frequently Asked Questions
-
What is the current ESSA Pharma Inc. (EPIX) stock price?
-
ESSA Pharma Inc.(NASDAQ:EPIX) stock price is $0.2012 in the last trading session. During the trading session, EPIX stock reached the peak price of $6.45 while $0.18 was the lowest point it dropped to. The percentage change in EPIX stock occurred in the recent session was --1.85% while the dollar amount for the price change in EPIX stock was -$0.0.
-
EPIX's industry and sector of operation?
-
The NASDAQ listed EPIX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of EPIX?
-
David Ross Parkinson | President, Chief Executive Officer & Director
Neil Thapar | Executive
Peter A. Virsik | Executive Vice President & Chief Operating Officer
Alessandra Cesano | Chief Medical Officer & Executive Vice President
Erin Rudsinski | Executive -
How many employees does EPIX have?
-
Number of EPIX employees currently stands at 35. EPIX operates from 999 West Broadway, Vancouver, BC V5Z 1K5, CA.
-
Link for EPIX official website?
-
Official Website of EPIX is: https://www.essapharma.com
-
How do I contact EPIX?
-
EPIX could be contacted at phone #17783310962 and can also be accessed through its website. EPIX operates from 999 West Broadway, Vancouver, BC V5Z 1K5, CA.
-
How many shares of EPIX are traded daily?
-
The average number of EPIX shares traded daily for last 3 months was 6.75M.
-
What is the market cap of EPIX currently?
-
The market value of EPIX currently stands at $9.52M with its latest stock price at $0.2012